In April 2022 United Kingdom Anti-Doping (UKAD) has reported an anti-doping rule violation against the boxer Amir Khan after his sample tested positive for the prohibited substance Enobosarm (Ostarine) in a low concentration.
Following notification a provisional suspension was ordered. The Athlete filed a statement in his defence and he was heard for the National Anti-Doping Panel.
The Athlete accepted the test result and denied the intentional use of the substance. However he was unable to demonstrate the source of the positive test because the supplements he used did not contain prohibited substances.
He asserted that he recently was tested without issues. Because of the low concentration found in his sample he assumed that a contaminated supplement was the source.
After assessment of the evidence and testimonies of experts witnesses the Panel deems that the Athlete had established that his violation was not intentional. The Panel regards that the objective scientific evidence ruled out any reckless conduct by the Athlete.
Further the Panel rejects the possibility that the Athlete had administered micro-doses of Ostarine or any dose that could enhance his sport performances. In this matter the Athlete was tested 7 days before what excludes the possible argument that the low concentration in his sample was the result of an effective dose Ostarine administered before 12 February 2022.
Therefore the National Anti-Doping Panel decides on 21 February 2023 to impose a 2 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 6 April 2022.
